Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27469417 | 1.00 | — | — | |
| SCHEMBL307359 | 0.95 | — | — | |
| Iodide SCHEMBL9536878 | 0.90 | — | — | |
| Bromide SCHEMBL11505136 | 0.90 | — | — | |
| SCHEMBL28868193 | 0.90 | — | — | |
| SCHEMBL29183241 | 0.90 | — | — | |
| Water SCHEMBL1971739 | 0.90 | — | — | |
| Iodide SCHEMBL28177761 | 0.86 | — | — | |
| SCHEMBL28215351 | 0.79 | NOS1 (0.35) | — | |
| SCHEMBL28111942 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 242 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250313801-A1 | SPECIFIC T CELL FOR PREVENTING OR TREATING CANCER, AND PREPARATION METHOD THEREOF | SUZHOU ERSHENG BIOPHARMACEUTICAL CO., LTD. (CN) | 2025-10-09 | — | — | US | claimed |
| CN-120004697-A | Preparation method of OrgVO material and application of OrgVO material as secondary battery anode material | 同济大学 | 2025-05-16 | — | — | CN | claimed |
| EP-4534652-A1 | SPECIFIC T CELL FOR PREVENTING OR TREATING CANCER, AND PREPARATION METHOD THEREFOR | Suzhou Ersheng Biopharmaceutical Co., Ltd. (CN) | 2025-04-09 | — | — | EP | claimed |
| CN-119331419-A | Impact-resistant plastic packaging material and preparation method thereof | 惠州市天富材料技术有限公司 | 2025-01-21 | — | — | CN | claimed |
| CN-119015834-A | Carbon dioxide separation membrane and preparation method thereof | 国家能源投资集团有限责任公司 | 2024-11-26 | — | — | CN | claimed |
| CN-118667104-A | Degradable high polymer material and preparation method thereof | 上海科技大学 | 2024-09-20 | — | — | CN | claimed |
| WO-2023227085-A1 | SPECIFIC T CELL FOR PREVENTING OR TREATING CANCER, AND PREPARATION METHOD THEREFOR | 苏州尔生生物医药有限公司 | 2023-11-30 | — | — | WO | claimed |
| CN-112952005-A | Solar cell and preparation method thereof | 南京邮电大学 | 2021-06-11 | — | — | CN | claimed |
| CN-110079020-A | A kind of new energy vehicle battery pack upper cover anti-flaming polypropylene material and preparation method thereof | 长沙而道新能源科技有限公司 | 2019-08-02 | — | — | CN | claimed |
| CN-109736091-A | A kind of anti pilling overcoat and its treatment process | 乐清市雅格狮丹服饰有限公司 | 2019-05-10 | — | — | CN | claimed |
| CN-105712939-B | A kind of method of synthesizing rosuvastatin spit of fland calcium key intermediate | 重庆安格龙翔医药科技有限公司 | 2018-01-23 | — | — | CN | claimed |
| CN-105622521-B | A kind of preparation method of rosuvastain calcium key intermediate | 重庆安格龙翔医药科技有限公司 | 2018-01-16 | — | — | CN | claimed |
| CN-105622522-B | A kind of synthetic method of rosuvastain calcium key intermediate | 重庆安格龙翔医药科技有限公司 | 2018-01-16 | — | — | CN | claimed |
| CN-106905673-A | A kind of high-tensile environmentally-friendly plastic Masterbatch macromolecule carrier and preparation method thereof | 李春霞 | 2017-06-30 | — | — | CN | claimed |
| CN-106590443-A | Radio frequency chip mounting binding agent | 华蓥旗邦微电子有限公司 | 2017-04-26 | — | — | CN | claimed |
| CN-106075577-A | Antibacterial coating based on organic guanidine salt and polyethylene glycol | 南京工业大学 | 2016-11-09 | — | — | CN | claimed |
| CN-105712939-A | Method used for synthesizing rosuvastatin calcium key intermediate | 重庆安格龙翔医药科技有限公司 | 2016-06-29 | — | — | CN | claimed |
| CN-105622521-A | Preparation method of rosuvastatin calcium key intermediate | CHONGQING ANGE LONGXIANG PHARMACEUTICAL CO LTD | 2016-06-01 | — | — | CN | claimed |
| CN-105622522-A | Synthetic method of rosuvastatin calcium key intermediate | CHONGQING ANGE LONGXIANG PHARMACEUTICAL CO LTD | 2016-06-01 | — | — | CN | claimed |
| CN-102936225-A | Method for preparing rosuvastatin calcium intermediate containing brooethyl, hydroxymethyl or formyl | JIANGSU ALPHA PHARMACEUTICAL CO LTD | 2013-02-20 | — | — | CN | claimed |